Skip to main content

Table 4 Mean and standard deviation of payments, by treatment modality

From: The cost burden of oral, oral pharyngeal, and salivary gland cancers in three groups: commercial insurance, medicare, and medicaid

 

TOTAL OC/OP/SG Cancer

Known Treatment Modalities

Unknown

P-valueB

  

Radiation

Surgery

Chemotherapy

Radiation + Chemotherapy

Surgery + Chemotherapy

Surgery + Radiation

Surgery + Radiation + Chemotherapy

TOTAL Known treatment modalities

  

COMMERCIAL

           

Number of enrollees

3,918

233

882

77

361

55

670

681

2959

959

 

Total $

79,151

105,422

32,476

79,072

137,315

137,277

110,679

153,892

99,822

15,373

<0.001

 

(86,170)

(82,487)

(47,082)

(72,498)

(77,676)

(125,408)

(75,189)

(92,759)

(88,715)

(25,828)

 

Rx Drug $

3,541

3,900

2,207

7,858

5,637

8,862

3,602

5,079

4,006

2,107

<0.001

 

(5,487)

(4,484)

(3,725)

(11,149)

(6,560)

(14,613)

(4,883)

(6,628)

(5,996)

(3,061)

 

ER $

723

1,614

330

637

1,641

495

1,035

805

871

265

<0.001

 

(4,282)

(6,465)

(1,679)

(1,624)

(9,247)

(1,127)

(5,063)

(3,571)

(4,854)

(1,403)

 

Inpatient $

20,691

18,778

15,950

20,623

24,166

51,659

28,778

38,334

26,017

4,257

<0.001

 

(44,150)

(43,736)

(38,519)

(31,899)

(43,557)

(95,505)

(44,889)

(60,405)

(48,933)

(14,789)

 

Outpatient $

54,197

81,130

13,989

49,954

105,871

76,260

77,264

109,674

68,927

8,745

<0.001

 

(60,854)

(61,492)

(16,468)

(52,256)

(58,144)

(84,987)

(54,602)

(57,678)

(62,582)

(17,619)

 

MEDICARE

           

Number of enrollees

2,303

130

660

53

150

69

434

281

1777

526

 

Total $

48,410

66,670

28,138

57,590

85,462

53,526

67,020

96,520

57,969

16,113

<0.001

 

(61,599)

(59,605)

(47,551)

(72,809)

(72,710)

(48,819)

(61,044)

(79,430)

(65,926)

(24,099)

 

Rx Drug $

3,798

4,362

3,232

6,056

4,332

6,400

3,622

5,102

4,006

3,096

<0.001

 

(4,558)

(5,284)

(3,249)

(5,723)

(4,428)

(6,749)

(3,918)

(4,932)

(4,323)

(5,220)

 

ER $

259

396

175

729

461

294

232

423

289

157

<0.001

 

(898)

(966)

(453)

(1,868)

(983)

(574)

(1,270)

(1,160)

(981)

(517)

 

Inpatient $

12,863

10,860

12,240

15,576

15,527

12,597

17,417

20,164

15,047

5,483

<0.001

 

(29,872)

(24,140)

(31,434)

(42,028)

(34,848)

(16,582)

(32,743)

(35,304)

(32,264)

(17,905)

 

Outpatient $

31,490

51,051

12,492

35,230

65,141

34,235

45,750

70,831

38,627

7,378

<0.001

 

(43,870)

(45,289)

(25,229)

(46,680)

(51,534)

(40,263)

(42,711)

(59,425)

(47,302)

(10,725)

 

MEDICAID

           

Number of enrollees

585

52

93

29

70

7

62

68

381

204

 

Total $

59,404

73,861

49,526

37,556

114,761

152,220

68,332

107,287

79,178

22,474

<0.001

 

(74,919)

(79,958)

(76,721)

(50,914)

(108,040)

(126,234)

(57,119)

(59,904)

(82,735)

  

Rx Drug $

5,254

4,612

4,063

4,936

12,224

19,478

4,306

6,159

6,401

3,113

<0.001

 

(7,614)

(5,556)

(5,309)

(6,440)

(14,169)

(21,473)

(4,612)

(4,571)

(8,770)

  

ER $

1,119

584

784

537

820

663

480

864

707

1,889

<0.001

 

(11,530)

(1,021)

(1,491)

(1,045)

(1,389)

(855)

(748)

(1,697)

(1,318)

  

Inpatient $

28,954

38,564

35,280

13,464

50,024

111,605

28,326

45,878

38,939

10,305

<0.001

 

(62,084)

(71,797)

(72,032)

(38,892)

(101,144)

(122,921)

(51,091)

(54,231)

(72,752)

  

Outpatient $

24,078

30,101

9,399

18,620

51,694

20,474

35,220

54,386

33,132

7,168

<0.001

 

(28,650)

(20,080)

(7,624)

(20,389)

(35,506)

(13,681)

(24,433)

(36,987)

(31,159)

  
  1. A. Total known modalities is the sum of previous 7 columns (radiation through surgery + radiation + chemotherapy.
  2. B. P-value is from chi square test for a significant difference between the treatment modalities (including unknown modality).
  3. Adjusted to 2009$.